Current Hypertension Reports

, 21:71 | Cite as

Ambulatory Blood Pressure Monitoring in Pediatrics

  • Sonali S. PatelEmail author
  • Stephen R. Daniels
Implementation to Increase Blood Pressure Control: What Works? (J Brettler and K Reynolds, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Implementation to Increase Blood Pressure Control: What Works?


Purpose of Review

This is a review of ambulatory blood pressure monitoring (ABPM) use in pediatrics, summarizing current knowledge and uses of ABPM.

Recent Findings

Updated guidelines from the American Academy of Pediatrics have emphasized the value of ABPM. ABPM is necessary to diagnose white coat hypertension, masked hypertension, and nocturnal hypertension associated with specific conditions. There is growing evidence that ABPM may be useful in these populations. ABPM has been demonstrated to be more predictive of end-organ damage in pediatric hypertension compared to office blood pressure.


ABPM is an important tool in the diagnosis and management of pediatric hypertension. Routine use of ABPM could potentially prevent early cardiovascular morbidity and mortality in a wide variety of populations.


Ambulatory blood pressure monitoring ABPM Pediatric hypertension Hypertension in children and adolescents Pediatric cardiovascular disease 


Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Chaudhuri A. Pediatric ambulatory blood pressure monitoring: diagnosis of hypertension. Pediatr Nephrol. 2013;28(7):995–9. Scholar
  2. 2.
    Veiga EV, Arcuri EA, Cloutier L, Santos JL. Blood pressure measurement: arm circumference and cuff size availability. Rev Lat Am Enfermagem. 2009;17(4):455–61. Scholar
  3. 3.
    Zaheer S, Watson L, Webb NJ. Unmet needs in the measurement of blood pressure in primary care. Arch Dis Child. 2014;99(5):463–4. Scholar
  4. 4.
    Burke MJ, Towers HM, O'Malley K, Fitzgerald DJ, O'Brien ET. Sphygmomanometers in hospital and family practice: problems and recommendations. Br Med J (Clin Res Ed). 1982;285(6340):469–71. Scholar
  5. 5.
    Thomas M, Radford T, Dasgupta I. Unvalidated blood pressure devices with small cuffs are being used in hospitals. BMJ. 2001;323(7309):398.CrossRefGoogle Scholar
  6. 6.
    Savoca MR, MacKey ML, Evans CD, Wilson M, Ludwig DA, Harshfield GA. Association of ambulatory blood pressure and dietary caffeine in adolescents. Am J Hypertens. 2005;18(1):116–20. Scholar
  7. 7.
    Flynn JT, Urbina EM. Pediatric ambulatory blood pressure monitoring: indications and interpretations. J Clin Hypertens (Greenwich). 2012;14(6):372–82. Scholar
  8. 8.
    Feber J, Litwin M. Blood pressure (BP) assessment-from BP level to BP variability. Pediatr Nephrol. 2016;31(7):1071–9. Scholar
  9. 9.
    • Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3). doi: Updated guidelines for pediatric hypertension from the American Academy of Pediatrics. An emphasis was placed on ABPM for evaluation and management of hypertension in children and adolescents. CrossRefGoogle Scholar
  10. 10.
    McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640–4, 4.e1. Scholar
  11. 11.
    Samuel JP, Bell CS, Hebert SA, Varughese A, Samuels JA, Tyson JE. Office blood pressure measurement alone often misclassifies treatment status in children with primary hypertension. Blood Press Monit. 2017;22(6):328–32. Scholar
  12. 12.
    Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014;63(5):1116–35. Scholar
  13. 13.
    • Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008;52(3):433–51. Contains detailed instructions on performing ABPM in children and adolescents. CrossRefPubMedGoogle Scholar
  14. 14.
    The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl):555–76.Google Scholar
  15. 15.
    Sinha MD, Booth CJ, Reid CJ. Factors affecting success of blood pressure measurements during ambulatory blood pressure monitoring in children with renal disease. Cardiol Young. 2011;21(3):310–6. Scholar
  16. 16.
    Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20(10):1995–2007.CrossRefGoogle Scholar
  17. 17.
    Andrade H, Pires A, Noronha N, Amaral ME, Lopes L, Martins P, et al. Importance of ambulatory blood pressure monitoring in the diagnosis and prognosis of pediatric hypertension. Rev Port Cardiol. 2018;37(9):783–9. Scholar
  18. 18.
    Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22(2):273–80.CrossRefGoogle Scholar
  19. 19.
    Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011;57(1):3–10. Scholar
  20. 20.
    Cuspidi C, Sala C, Tadic M, Gherbesi E, De Giorgi A, Grassi G, et al. Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review. J Clin Hypertens (Greenwich). 2017;19(7):713–21. Scholar
  21. 21.
    • Macumber IR, Weiss NS, Halbach SM, Hanevold CD, Flynn JT. The association of pediatric obesity with nocturnal non-dipping on 24-hour ambulatory blood pressure monitoring. Am J Hypertens. 2016;29(5):647–52. Retrospective study of 247 obese and 161 lean children. Obese children were more likely to be non-dipping. No association was noted between non-dipping and left ventricular hypertrophy. CrossRefPubMedGoogle Scholar
  22. 22.
    Krzych LJ, Szydlowski L. Determinants of inappropriate circadian blood pressure variability in children with essential hypertension. Can J Cardiol. 2009;25(1):e13–6. Scholar
  23. 23.
    Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407–15. Scholar
  24. 24.
    Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793–801.CrossRefGoogle Scholar
  25. 25.
    Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46(1):156–61. Scholar
  26. 26.
    Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561–6. Scholar
  27. 27.
    Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.CrossRefGoogle Scholar
  28. 28.
    Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113(2):328–33.CrossRefGoogle Scholar
  29. 29.
    Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903–8.CrossRefGoogle Scholar
  30. 30.
    Maggio AB, Aggoun Y, Marchand LM, Martin XE, Herrmann F, Beghetti M, et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr. 2008;152(4):489–93. Scholar
  31. 31.
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340(1):14–22. Scholar
  32. 32.
    Litwin M, Niemirska A, Sladowska J, Antoniewicz J, Daszkowska J, Wierzbicka A, et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol. 2006;21(6):811–9. Scholar
  33. 33.
    Stabouli S, Kotsis V, Papamichael C, Constantopoulos A, Zakopoulos N. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr. 2005;147(5):651–6. Scholar
  34. 34.
    Al-Shorman A, Al-Domi H, Al-Atoum M. The associations of body composition and anthropometric measures with carotid intima-media thickness in obese and non-obese schoolchildren: a possible predictor for cardiovascular diseases. Vascular. 2018;26(3):285–90. Scholar
  35. 35.
    Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension. 2006;48(1):40–4. Scholar
  36. 36.
    Georgakis MK, Synetos A, Mihas C, Karalexi MA, Tousoulis D, Seshadri S, et al. Left ventricular hypertrophy in association with cognitive impairment: a systematic review and meta-analysis. Hypertens Res. 2017;40(7):696–709. Scholar
  37. 37.
    Peterson CG, Miyashita Y. The use of ambulatory blood pressure monitoring as standard of care in pediatrics. Front Pediatr. 2017;5:153. Scholar
  38. 38.
    Lande MB, Kaczorowski JM, Auinger P, Schwartz GJ, Weitzman M. Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States. J Pediatr. 2003;143(6):720–4. Scholar
  39. 39.
    Lande MB, Batisky DL, Kupferman JC, Samuels J, Hooper SR, Falkner B, et al. Neurocognitive function in children with primary hypertension. J Pediatr. 2017;180:148–55.e1. Scholar
  40. 40.
    • Kupferman JC, Batisky DL, Samuels J, Adams HR, Hooper SR, Wang H, et al. Ambulatory blood pressure monitoring and neurocognitive function in children with primary hypertension. Pediatr Nephrol. 2018;33(10):1765–71. A study of 75 children with untreated primary hypertension matched to 75 normotensive controls. ABPM was superior to office BP in identification of lower neurocognitive test performance. CrossRefPubMedGoogle Scholar
  41. 41.
    Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20(8):1151–5. Scholar
  42. 42.
    Sorof JM, Poffenbarger T, Franco K, Portman R. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001;14(9 Pt 1):855–60. Scholar
  43. 43.
    Cohen JB, Lotito MJ, Trivedi UK, Denker MG, Cohen DL, Townsend RR. Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis. Ann Intern Med. 2019. Scholar
  44. 44.
    Franklin SS, Thijs L, Hansen TW, O'Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–7. Scholar
  45. 45.
    Mancia G, Facchetti R, Grassi G, Bombelli M. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension. Hypertension. 2015;66(2):437–44. Scholar
  46. 46.
    Siven SS, Niiranen TJ, Kantola IM, Jula AM. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study. J Hypertens. 2016;34(1):54–60. Scholar
  47. 47.
    Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007;150(5):491–7. Scholar
  48. 48.
    McNiece KL, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50(2):392–5. Scholar
  49. 49.
    Lande MB, Meagher CC, Fisher SG, Belani P, Wang H, Rashid M. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008;153(1):50–4. Scholar
  50. 50.
    Gupta-Malhotra M, Hamzeh RK, Poffenbarger T, McNiece-Redwine K, Hashmi SS. Myocardial performance index in childhood onset essential hypertension and white coat hypertension. Am J Hypertens. 2016;29(3):379–87. Scholar
  51. 51.
    Pall D, Juhasz M, Lengyel S, Molnar C, Paragh G, Fulesdi B, et al. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. J Hypertens. 2010;28(10):2139–44. Scholar
  52. 52.
    Litwin M, Niemirska A, Ruzicka M, Feber J. White coat hypertension in children: not rare and not benign? J Am Soc Hypertens. 2009;3(6):416–23. Scholar
  53. 53.
    Miyashita Y, Flynn JT, Hanevold CD. Diagnosis and management of white-coat hypertension in children and adolescents: a Midwest Pediatric Nephrology Consortium study. J Clin Hypertens (Greenwich). 2017;19(9):884–9. Scholar
  54. 54.
    Iturzaeta A, Pompozzi L, Casas Rey C, Passarelli I, Torres F. Prevalence of masked hypertension among children with risk factors for arterial hypertension. Arch Argent Pediatr. 2018;116(5):328–32. Scholar
  55. 55.
    Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45(4):493–8. Scholar
  56. 56.
    Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010;21(1):137–44. Scholar
  57. 57.
    Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol. 2004;19(6):651–4. Scholar
  58. 58.
    Luo XX, Zhu Y, Sun Y, Ge Q, Su J, So HK, et al. Does masked hypertension cause early left ventricular impairment in youth? Front Pediatr. 2018;6:167. Scholar
  59. 59.
    So HK, Yip GW, Choi KC, Li AM, Leung LC, Wong SN, et al. Association between waist circumference and childhood-masked hypertension: a community-based study. J Paediatr Child Health. 2016;52(4):385–90. Scholar
  60. 60.
    Samuels J, Ng D, Flynn JT, Mitsnefes M, Poffenbarger T, Warady BA, et al. Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension. 2012;60(1):43–50. Scholar
  61. 61.
    Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639–50. Scholar
  62. 62.
    Vidi SR. Role of hypertension in progression of chronic kidney disease in children. Curr Opin Pediatr. 2018;30(2):247–51. Scholar
  63. 63.
    Seeman T, Simkova E, Kreisinger J, Vondrak K, Dusek J, Gilik J, et al. Improved control of hypertension in children after renal transplantation: results of a two-yr interventional trial. Pediatr Transplant. 2007;11(5):491–7. Scholar
  64. 64.
    Seeman T, Vondrak K, Dusek J. Effects of the strict control of blood pressure in pediatric renal transplant recipients-ESCORT trial. Pediatr Transplant. 2019;23(1):e13329. Scholar
  65. 65.
    McLin VA, Anand R, Daniels SR, Yin W, Alonso EM. Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant. 2012;12(1):183–90. Scholar
  66. 66.
    Abu-Elmagd KM, Kosmach-Park B, Costa G, Zenati M, Martin L, Koritsky DA, et al. Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation. Ann Surg. 2012;256(3):494–508. Scholar
  67. 67.
    Tainio J, Qvist E, Miettinen J, Holtta T, Pakarinen M, Jahnukainen T, et al. Blood pressure profiles 5 to 10 years after transplant in pediatric solid organ recipients. J Clin Hypertens (Greenwich). 2015;17(2):154–61. Scholar
  68. 68.
    Hryniewiecka E, Pilecki T, Zieniewicz K, Paczek L. Circadian and short-term blood pressure abnormalities after liver transplantation. Clin Exp Hypertens. 2018;40(8):730–3. Scholar
  69. 69.
    Del Compare ME, D'Agostino D, Ferraris JR, Boldrini G, Waisman G, Krmar RT. Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatr Transplant. 2004;8(5):496–501. Scholar
  70. 70.
    O'Sullivan JJ, Derrick G, Gray J. Blood pressure after cardiac transplantation in childhood. J Heart Lung Transplant. 2005;24(7):891–5. Scholar
  71. 71.
    Gupta-Malhotra M, Banker A, Shete S, Hashmi SS, Tyson JE, Barratt MS, et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens. 2015;28(1):73–80. Scholar
  72. 72.
    Brown ML, Burkhart HM, Connolly HM, Dearani JA, Cetta F, Li Z, et al. Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol. 2013;62(11):1020–5. Scholar
  73. 73.
    Tong F, Li ZQ, Li L, Chong M, Zhu YB, Su JW, et al. The follow-up surgical results of coarctation of the aorta procedures in a cohort of Chinese children from a single institution. Heart Lung Circ. 2014;23(4):339–46. Scholar
  74. 74.
    Padang R, Dennis M, Semsarian C, Bannon PG, Tanous DJ, Celermajer DS, et al. Detection of serious complications by MR imaging in asymptomatic young adults with repaired coarctation of the aorta. Heart Lung Circ. 2014;23(4):332–8. Scholar
  75. 75.
    Lee MG, Allen SL, Kawasaki R, Kotevski A, Koleff J, Kowalski R, et al. High prevalence of hypertension and end-organ damage late after coarctation repair in normal arches. Ann Thorac Surg. 2015;100(2):647–53. Scholar
  76. 76.
    Macumber I. Ambulatory blood pressure monitoring in children and adolescents: a review of recent literature and new guidelines. Curr Hypertens Rep. 2017;19(12):96. Scholar
  77. 77.
    Downie ML, Ulrich EH, Noone DG. An update on hypertension in children with type 1 diabetes. Can J Diabetes. 2018;42(2):199–204. Scholar
  78. 78.
    Kir M, Cetin B, Demir K, Yilmaz N, Kizilca O, Demircan T, et al. Can ambulatory blood pressure monitoring detect early diastolic dysfunction in children with type 1 diabetes mellitus: correlations with B-type natriuretic peptide and tissue Doppler findings. Pediatr Diabetes. 2016;17(1):21–7. Scholar
  79. 79.
    Lee SH, Kim JH, Kang MJ, Lee YA, Won Yang S, Shin CH. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(10):2180–5. Scholar
  80. 80.
    Dost A, Bechtold-Dalla Pozza S, Bollow E, Kovacic R, Vogel P, Feldhahn L, et al. Blood pressure regulation determined by ambulatory blood pressure profiles in children and adolescents with type 1 diabetes mellitus: impact on diabetic complications. Pediatr Diabetes. 2017;18(8):874–82. Scholar
  81. 81.
    Shikha D, Singla M, Walia R, Potter N, Umpaichitra V, Mercado A, et al. Ambulatory blood pressure monitoring in lean, obese and diabetic children and adolescents. Cardiorenal Med. 2015;5(3):183–90. Scholar
  82. 82.
    Dart AB, Wicklow BA, Sellers EA, Dean HJ, Malik S, Walker J, et al. The improving renal complications in adolescents with type 2 diabetes through the REsearch (iCARE) Cohort Study: rationale and protocol. Can J Diabetes. 2014;38(5):349–55. Scholar
  83. 83.
    Dart AB, Wicklow B, Blydt-Hansen TD, Sellers EAC, Malik S, Chateau D, et al. A holistic approach to risk for early kidney injury in indigenous youth with type 2 diabetes: a proof of concept paper from the iCARE cohort. Can J Kidney Health Dis. 2019;6:2054358119838836. Scholar
  84. 84.
    Kang KT, Chiu SN, Weng WC, Lee PL, Hsu WC. Analysis of 24-hour ambulatory blood pressure monitoring in children with obstructive sleep apnea: a hospital-based study. Medicine (Baltimore). 2015;94(40):e1568. Scholar
  85. 85.
    Madaeva I, Berdina O, Polyakov V, Kolesnikov S. Obstructive sleep apnea and hypertension in adolescents: effect on neurobehavioral and cognitive functioning. Can Respir J. 2016;2016:3950914–6. Scholar
  86. 86.
    Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, et al. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008;51(1):84–91. Scholar
  87. 87.
    Ng DK, Wong JC, Chan CH, Leung LC, Leung SY. Ambulatory blood pressure before and after adenotonsillectomy in children with obstructive sleep apnea. Sleep Med. 2010;11(7):721–5. Scholar
  88. 88.
    Hsu WC, Kang KT, Chiu SN, Weng WC, Lee PL, Lin CY. 24-Hour ambulatory blood pressure after adenotonsillectomy in childhood sleep apnea. J Pediatr. 2018;199:112–7.e6. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pediatrics, Section of Cardiology, Children’s Hospital ColoradoUniversity of Colorado School of MedicineAuroraUSA

Personalised recommendations